Pharming Group N.V. (AMS: PHARM)

Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	84	90.23	80.86	93.76	139.9	76.89
Cash & Short-Term Investments	84	90.23	80.86	93.76	139.9	76.89
Cash Growth	176.86%	11.58%	-13.75%	-32.98%	81.95%	-19.03%
Accounts Receivable	380.36	328.03	282.83	173.69	180.27	173.82
Other Receivables	5.62	23.68	16.77	86.21	12.38	82.24
Receivables	385.98	351.71	299.6	259.9	192.65	256.06
Prepaid Expenses	-	7.1	6.44	6.06	4.05	7.86
Restricted Cash	13.18	14.56	6.77	5.42	10.08	7.74
Total Current Assets	483.16	463.58	393.67	365.14	346.68	348.55
Property, Plant & Equipment	47.17	49.18	55.58	49.8	44.98	48.66
Goodwill	45.96	44.27	44.44	42.55	8.48	8.61
Other Intangible Assets	24.12	24.66	21.26	17.47	8.49	10.95
Long-Term Deferred Tax Assets	17.5	17.27	14.73	13.34	12.42	13.42
Other Long-Term Assets	1.87	5.62	8.77	12.87	5	7.29
Total Assets	625.38	611.28	547.14	501.8	426.04	437.48
Accounts Payable	145.75	24.56	22.9	19.15	15.36	16.82
Accrued Expenses	-	102.93	95.43	93.7	78.92	90.37
Current Portion of Leases	11.87	12.18	13.18	11.97	11.49	14.94
Current Income Taxes Payable	16.02	16.41	11.93	15.07	9.59	4.31
Other Current Liabilities	-	22.61	12.3	12.05	4.33	4.12
Total Current Liabilities	173.65	178.68	155.74	151.94	119.69	130.57
Long-Term Debt	111.16	78.59	18.63	-	-	-
Long-Term Leases	24.91	27.03	32.45	30.18	24.97	27.6
Long-Term Deferred Tax Liabilities	2.46	2.46	1.78	2.25	0.12	0.32
Other Long-Term Liabilities	12.42	10.21	19.22	13.28	4.22	3.08
Total Liabilities	324.61	298.75	229.32	199.87	151.26	163.64
Common Stock	1.52	1.52	1.52	1.52	1.52	1.52
Additional Paid-In Capital	86.15	86.15	86.15	86.15	86.15	86.15
Retained Earnings	14.94	208.04	204.3	196.83	191.46	183.17
Comprensive Income & Other	194.76	5.75	12.72	3.75	-6.49	7.4
Total Common Equity	297.36	301.45	304.68	288.24	272.64	278.23
Minority Interest	3.41	11.08	13.14	13.69	2.14	-4.4
Shareholders' Equity	300.77	312.54	317.82	301.93	274.78	273.84
Total Liabilities & Equity	625.38	611.28	547.14	501.8	426.04	437.48
Total Debt	147.95	117.8	64.26	42.14	36.45	42.54
Net Cash (Debt)	-63.94	-27.57	16.6	51.61	103.45	34.35
Net Cash Growth	-	-	-67.83%	-50.11%	201.12%	-63.82%
Net Cash Per Share	-1.27	-0.55	0.33	1.02	2.05	0.68
Filing Date Shares Outstanding	50.45	50.4	50.4	50.4	50.57	50.57
Total Common Shares Outstanding	50.45	50.4	50.4	50.4	50.57	50.57
Working Capital	309.51	284.9	237.94	213.2	226.99	217.98
Book Value Per Share	5.89	5.98	6.05	5.72	5.39	5.50
Tangible Book Value	227.28	232.53	238.98	228.21	255.67	258.67
Tangible Book Value Per Share	4.50	4.61	4.74	4.53	5.06	5.11
Machinery	-	37.29	35.07	33.17	31.09	30.8

Source: S&P Capital IQ. Standard template. Financial Sources.